日本薬理学会年会要旨集
Online ISSN : 2435-4953
WCP2018 (The 18th World Congress of Basic and Clinical Pharmacology)
セッションID: WCP2018_PO3-6-33
会議情報

Poster session
Pentamethylquercetin counteracts obesity and drives brown fat-like phenotype through AMPK-mediated activation of PGC-1 alpha/FNDC5 pathway in muscle
Hui LiuJian-zhao WuJing-xia DuMan-wen Jin
著者情報
会議録・要旨集 オープンアクセス

詳細
抄録

BACKGROUND/OBJECTIVES: To determine the effect of pentamethylquercetin (PMQ), a natural methylated quercetin derivative, on beige/brite adipocyte formation in inguinal white adipose tissue (ingWAT), and to explore its underlying mechanisms.

METHODS: Monosodium glutamate (MSG)-induced obese mice, which exhibit obesity and insulin resistance, were administered orally with PMQ at doses of 5, 10 and 20 mg/kg/d for 19 consecutive weeks. Histologic and molecular changes were examined to evaluate the browning effects of PMQ on ingWAT and the involvement of AMPK/PGC-1alpha/FNDC5 pathway was also investigated in vivo and in vitro.

RESULTS: PMQ treatment significantly improved the metabolic parameters of MSG-induced obese mice. Concomitantly, PMQ markedly induced the development of brown-like adipocytes and significantly increased UCP-1 protein level and mRNA expression of brown-fat specific genes and beige cell markers in ingWAT. Furthermore, PMQ dose-dependently upregulated the expression levels of AMPK-PGC-1alpha-FNDC5 signaling and stimulated irisin secretion in MSG mice and C2C12 myotubes. More importantly, myotube conditioned medium (MCM) after PMQ incubation generated the browning effect on 3T3-L1 cells, which could be effectively suppressed by anti-FNDC5. Meanwhile, PGC-1alpha knockdown abrogated the promoting effects of MCM incubated by PMQ on UCP-1 expression in 3T3-L1 cells. In addition, an AMPK inhibitor, compound C dramatically reduced protein levels of PGC-1alpha and FNDC5 induced by PMQ in C2C12 myotubes.

CONCLUSIONS: Our findings suggest that PMQ exerts its beiging effects on ingWAT in MSG mice, which may be attributed to activation of AMPK/PGC-1alpha/FNDC5 signaling pathway in skeletal muscle.

著者関連情報
© 2018 The Authors(s)
前の記事 次の記事
feedback
Top